Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tao Han

Showing results (1201-1210 of 1,220) with videos related to

Pageof 122
Sort By:
Hepatology Research : the Official Journal of the Japan Society of Hepatology|March 6, 2020
Artificial liver treatment improves survival in patients with hepatitis B virus-related acute-on-chronic liver failure: A case-control matched analysisLingling Yang, Tianzhou Wu, Jiang Li, et al.
Protein & Cell|November 27, 2023
Senktide blocks aberrant RTN3 interactome to retard memory decline and tau pathology in social isolated Alzheimer's disease miceHe-Zhou Huang, Wen-Qing Ai, Na Wei, et al.
Journal of Viral Hepatitis|January 10, 2019
Early steep decline of liver stiffness predicts histological reversal of fibrosis in chronic hepatitis B patients treated with entecavirYuanyuan Kong, Yameng Sun, Jialing Zhou, et al.
Gut|September 21, 2017
Development of diagnostic criteria and a prognostic score for hepatitis B virus-related acute-on-chronic liver failureTianzhou Wu, Jiang Li, Li Shao, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 6, 2021
Pradefovir Treatment in Patients With Chronic Hepatitis B: Week 24 Results From a Multicenter, Double-Blind, Randomized, Noninferiority, Phase 2 TrialYanhang Gao, Fei Kong, Xinwen Song, et al.
The Journal of Infection|February 23, 2025
Efficacy and safety of GLS4 with entecavir vs entecavir alone in chronic hepatitis B patients: A multicenter clinical trialMingyuan Zhang, Yanhang Gao, Fei Kong, et al.
Toxicologic Pathology|January 28, 2009
The liver toxicity biomarker study: phase I design and preliminary resultsRobert N McBurney, Wade M Hines, Linda S Von Tungeln, et al.
Frontiers in Immunology|December 26, 2022
Effect of inactivated COVID-19 vaccines on seizure frequency in patients with epilepsy: A multicenter, prospective studyXiqin Fang, Shimin Hu, Tao Han, et al.
Journal of Hepatology|November 17, 2021
Effect of sarcopenia on survival in patients with cirrhosis: A meta-analysisXinxing Tantai, Yi Liu, Yee Hui Yeo, et al.
Toxicologic Pathology|May 11, 2012
The liver toxicity biomarker study phase I: markers for the effects of tolcapone or entacaponeRobert N McBurney, Wade M Hines, Linda S VonTungeln, et al.
Pageof 122

Showing results (1201-1210 of 1,220) with videos related to

Sort By:
Pageof 122
Hepatology Research : the Official Journal of the Japan Society of Hepatology|March 6, 2020
Artificial liver treatment improves survival in patients with hepatitis B virus-related acute-on-chronic liver failure: A case-control matched analysisLingling Yang, Tianzhou Wu, Jiang Li, et al.
Protein & Cell|November 27, 2023
Senktide blocks aberrant RTN3 interactome to retard memory decline and tau pathology in social isolated Alzheimer's disease miceHe-Zhou Huang, Wen-Qing Ai, Na Wei, et al.
Journal of Viral Hepatitis|January 10, 2019
Early steep decline of liver stiffness predicts histological reversal of fibrosis in chronic hepatitis B patients treated with entecavirYuanyuan Kong, Yameng Sun, Jialing Zhou, et al.
Gut|September 21, 2017
Development of diagnostic criteria and a prognostic score for hepatitis B virus-related acute-on-chronic liver failureTianzhou Wu, Jiang Li, Li Shao, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 6, 2021
Pradefovir Treatment in Patients With Chronic Hepatitis B: Week 24 Results From a Multicenter, Double-Blind, Randomized, Noninferiority, Phase 2 TrialYanhang Gao, Fei Kong, Xinwen Song, et al.
The Journal of Infection|February 23, 2025
Efficacy and safety of GLS4 with entecavir vs entecavir alone in chronic hepatitis B patients: A multicenter clinical trialMingyuan Zhang, Yanhang Gao, Fei Kong, et al.
Toxicologic Pathology|January 28, 2009
The liver toxicity biomarker study: phase I design and preliminary resultsRobert N McBurney, Wade M Hines, Linda S Von Tungeln, et al.
Frontiers in Immunology|December 26, 2022
Effect of inactivated COVID-19 vaccines on seizure frequency in patients with epilepsy: A multicenter, prospective studyXiqin Fang, Shimin Hu, Tao Han, et al.
Journal of Hepatology|November 17, 2021
Effect of sarcopenia on survival in patients with cirrhosis: A meta-analysisXinxing Tantai, Yi Liu, Yee Hui Yeo, et al.
Toxicologic Pathology|May 11, 2012
The liver toxicity biomarker study phase I: markers for the effects of tolcapone or entacaponeRobert N McBurney, Wade M Hines, Linda S VonTungeln, et al.
Pageof 122